Skeletal muscle mitochondria from AZT-treated rats have a diminished response to chronic electrical stimulation

Journal of Applied Physiology

Volumn 81, Issue 1, 1996, Pages 326-334

  McCurdy III, Daniel T ^a   Kennedy, John M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

cytochrome oxidase; electron microscopy; mitochondrial DNA; mRNA

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; ZIDOVUDINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUSCLE EXCITATION; MUSCLE MITOCHONDRION; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030016871     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.81.1.326     Document Type: Article

References (45)

1. Anderson, S., A. Bankier, B. Barrel, M. DeBruijn, A. Roe, F. Sanger, P. Drouin, P. Schrier, A. Smith, R. Staden, and I. Young. Sequence and organization of the human mitochondrial genome. Nature Lond. 290: 457-465, 1981.
2. Arnaudo, E., M. Dalakas, S. Shanske, C. T. Moraes, S. DiMauro, and E. Schon. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337: 508-510, 1991.
3. Bolden, A., G. Pedrali, and A. Weissbach. DNA polymerase of mitochondria is a gamma-polymerase. J. Biol. Chem. 252: 3351-3356, 1977.
4. Bucher, T., W. Luh, and D. Pette. Einfache und zusammengesetzte optische Tests mit Pyridinnucleotiden. In: Handbuch der physiologisch und pathologisch-chemischen Analyse, edited by K. Lang and E. Lehnhartz. Berlin: Springer, 1964, p. 292-339.
5. Chalmers, A. C., C. M. Greco, and R. G. Miller. Prognosis in AZT myopathy. Neurology 41: 1181-1184, 1991.
6. Chariot, P., I. Monnet, and R. Gherardi. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann. Neurol. 34: 561-565, 1993.
7. Chariot, P., I. Monnet, M. Mouchet, M. Rohr, J. Lefaucheur, M. Dubreuil-Lemaire, M. Chousterman, and R. Gherardi. Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis Rheum. 37: 583-586, 1994.
8. Chen, C., M. Vazquez-Padua, and Y. Cheng. Effect of antiimmunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol. 39: 625-628, 1991.
9. Chomoczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
10. Cooperstein, S. J., and A. Lazarow. A microspectrophotometric method for the determination of cytochrome oxidase. J. Biol. Chem. 189: 665-670, 1951.
11. Dalakas, M. C., I. Illa, G. H. Pezeshkpour, J. P. Laukaitis, B. Cohen, and J. L. Griffin. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322: 1098-1105, 1990.
12. Dalakas, M. C., G. H. Pezeshkpour, M. Gravell, and J. L. Sever. Polymyositis associated with AIDS retrovirus. J. Am. Med. Assoc. 256: 2381-2383, 1986.
13. Eisenberg, B. R. Quantitative ultrastructure of mammalian skeletal muscle. In: Handbook of Physiology. Skeletal Muscle. Bethesda, MD: Am. Physiol. Soc., 1983, sect. 10, chapt. 3, p. 73-112.
14. Gorand, D., K. Henry, and R. Giloff. Necrotizing myopathy and zidovudine (Letter). Lancet 1: 1050, 1988.
15. Helbert, M., T. Fletcher, B. Peddle, J. Harris, and A. Pinching. Zidovudine-associated myopathy. Lancet 2: 689-690, 1988.
16. Hood, D. Co-ordinate expression of cytochrome c oxidase subunit III and VIc mRNAs in rat tissues. Biochem. J. 269: 503-506, 1990.
17. Hood, D., J. Simoneau, A. Kelly, and D. Pette. Effect of thyroid status on the expression of metabolic enzymes during chronic stimulation. Am. J. Physiol. 263 (Cell Physiol. 32): C788-C793, 1992.
18. Hood, D., R. Zak, and D. Pette. Chronic stimulation of rat skeletal muscle induces coordinate increases in mitochondrial and nuclear mRNAs of cytochrome c oxidase subunits. Eur. J. Biochem. 179: 275-280, 1989.
19. Kennedy, J. M., S. Lobacz, and S. Kelley. Mitochondrial DNA replication and transcription are dissociated during embryonic cardiac hypertrophy. Am. J. Physiol. 261 (Cell Physiol. 30): C1091-C1098, 1991.
20. Kolarov, J., S. Kuzela, A. Wielburski, and B. Nelson. The characterization of mitochondrial translation products in rat liver and rat hepatoma cells. FEBS Lett. 126: 61-65, 1981.
21. Lamperth, L., M. C. Dalakas, F. Dagani, J. Anderson, and R. Ferrari. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest. 65: 742-751, 1991.
22. Lewis, W., B. Gonzalez, A. Chomyn, and T. Papoian. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J. Clin. Invest. 89: 1354-1360, 1992.
23. Lewis, W., T. Papoian, B. Gonzalez, H. Louie, D. Kelly, M. Payne, and W. Grody. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab. Invest. 65: 228-236, 1991.
24. Lewis, W., J. F. Simpson, and R. R. Meyer. Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine. Circ. Res. 74: 344-348, 1994.
25. Lowry, O., H. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
26. Mhiri, C., M. Baudrimont, G. Bonne, C. Geny, F. Degoul, C. Marsac, E. Roullet, and R. Gherardi. Zidovudine myopadistinctive disorder associated with mitochondrial dysfunction. Ann. Neurol. 29: 606-614, 1991.
27. Miller, R., P. Carson, R. Moussavi, A. Green, A. Baker, and M. Weiner. Fatigue and myalgia in AIDS patients. Neurology 41: 1603-1607, 1991.
28. Ohira, Y., L. Cartier, M. Chen, and J. Holloszy. Induction of an increase in mitochondrial matrix enzymes in muscle of iron-deficient rats. Am. J. Physiol. 253 (Cell Physiol. 22): C639-C644, 1987.
29. Pette, D., and G. Vrbova. Adaptation of mammalian skeletal muscle fibers to chronic electrical stimulation. Rev. Physiol. Biochem. Pharmacol. 120: 115-202, 1992.
30. Pinching, A. J., M. Helbert, B. Peddle, D. Robinson, K. Janes, D. Gor, D. J. Jeffries, C. Stoneham, D. Mitchell, A. E. Kocsis, J. Mann, S. M. Forster, and J. R. W. Harris. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex. J. Infect. 18: 33-40, 1989.
31. Rabinowitz, M., J. Sinclair, L. DeSalle, R. Haselkorn, and H. H. Swift. Isolation of deoxyribonucleic acid from mitochondria of chick embryo heart and liver. Proc. Natl. Acad. Sci. USA 53: 1126-1133, 1965.
32. Richman, D. D., M. A. Fischl, M. H. Grieco, M. S. Gottlieb, P. A. Volberding, O. L. Laskin, J. M. Leedom, J. E. Groopman, D. Mildvan, M. S. Hirsch, G. G. Jackson, D. T. Durack, S. Nusinoff-Lehrman, and AZT Collarborative Working Group. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 317: 192-197, 1987.
33. Sambrook, J., E. Fritsch, and T. Maniatis. Molecular Cloning: a Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1989.
34. Semino-Mora, M. C., M. E. Leon-Monzon, and M. C. Dalakas. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. I. L-Carnitine prevents the myotoxicity of AZT in vitro. Lab. Invest. 71: 102-112, 1994.
35. Simpson, D. M. Myopathy associated with human immunodeficiency virus (HIV) but not with zidovudine. Ann. Intern. Med. 109: 842, 1988.
36. Srere, P.A. Citrate synthase. Methods Enzymol. 13: 3-6, 1969.
37. Takahashi, M., A. Rana, and D. Hood. Portable electrical stimulator for use in small animals. J. Appl. Physiol. 74: 942-945, 1993.
38. Virbasius, J. V., and R. C. Scarpulla. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc. Natl. Acad. Sci. USA 91: 1309-1313, 1994.
39. 31P magnetic resonance spectroscopy suggests im-paired mitochondrial function in AZT-treated HIV-infected patients. Neurology 42: 619-623, 1992.
40. Wicks, K., and D. Hood. Mitochondrial adaptations in denervated muscle: relationship to muscle performance. Am. J. Physiol. 260 (Cell Physiol. 29): C841-C850, 1991.
41. Wiesner, R., T. Kurowski, and R. Zak. Regulation by thyroid hormone of nuclear and mitochondrial genes encoding subunits of cytochrome c oxidase in rat liver and skeletal muscle. Mol. Endocrinol. 6: 1458-1467, 1992.
42. Wiesner, R., H. Swift, and R. Zak. Purification of mitochondrial DNA from total cellular DNA of small tissue samples. Gene 98: 277-281, 1991.
43. Williams, R. S., S. Salmons, E. A. Newsholme, R. E. Kaufman, and J. Mellor. Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. J. Biol. Chem. 261: 376-380, 1986.
44. Willis, W. T., G. A. Brooks, S. A. Henderson, and P. R. Dallman. Effects of iron deficiency and training on mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 62: 2442-2446, 1987.
45. World Health Organization. The Current Global Situation of the HIVIAIDS Pandemic. Geneva, Switzerland: World Health Organization/Global Programme on AIDS, 1994.